IBM Watson Health cuts back Drug Discovery 'artificial intelligence' after lackluster sales

And seemingly uses machine learning to explain why it's kinda not but kinda is

IBM Watson Health is tapering off its Drug Discovery program, which uses "AI" software to help companies develop new pharmaceuticals, blaming poor sales."